# OnCo record utrxmycn-m1-14 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/utrxmycn-m1-14/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "utrxmycn-m1-14" ;
  schema:name "UTRxMYCN M1-14"@en ;
  schema:alternateName "3'UTRMYCN M1-14"@en ;
  schema:description "UTRxMYCN M1-14 is an experimental RNA medicine from UTR Therapeutics that makes the message of the cancer gene MYCN break down. It has been tested only in the laboratory, and the FDA has given it orphan drug status for soft tissue sarcoma."@en ;
  schema:url <https://onco.cc/drugs/utrxmycn-m1-14/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.utrtherapeutics.com/>, <https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=1182626> ;
  onco:status "preclinical" ;
  onco:tag "pipeline", "orphan-designation" ;
  onco:modality "Synthetic mRNA (RNA overwriting)" ;
  onco:cancers <https://onco.cc/cancers/sarcoma/>, <https://onco.cc/cancers/rhabdomyosarcoma/> ;
  onco:targets <https://onco.cc/targets/mycn/> ;
  onco:companies <https://onco.cc/companies/utr-therapeutics/> .